-

LIVE NATION UPDATE: Rosen Law Firm Provides Live Nation Entertainment, Inc. Investors Update in Securities Class Action – LYV

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, provides this update to purchasers of Live Nation Entertainment, Inc. (NYSE: LYV) securities in regard to the pending securities class action seeking recovery of investor losses. The suit alleges that Live Nation and certain of its officers and directors issued materially false and misleading statements to investors arising from Live Nation’s improper anticompetitive conduct.

On October 18, 2023, the United States District Court for the Central District of California appointed The Rosen Law Firm as Co-Lead Counsel in this securities class action. On February 23, 2024, the Court denied the defendants’ motion to dismiss. The case is currently in the discovery phase.

If you require additional information or want to join the Live Nation class action, go to https://rosenlegal.com/submit-form/?case_id=18184 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed.

If you purchased Live Nation securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

The Rosen Law Firm, P.A.

NYSE:LYV

Release Versions

Contacts

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

More News From The Rosen Law Firm, P.A.

Rosen Law Firm Encourages Xponential Fitness Inc. Investors to Inquire About Securities Class Action Investigation – XPOF

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Xponential Fitness Inc. (NYSE: XPOF) resulting from allegations that Xponential may have issued materially misleading business information to the investing public. So What: If you purchased Xponential securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arra...

Verrica Pharmaceuticals Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA). If you currently own shares of Verrica Pharmaceuticals stock, please visit the firm’s website at https://rosenlegal.com/submit-form/?case_id=6828 for more information. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at case@rosenleg...

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation – IRON

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public. So What: If you purchased Disc Medicine securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency...
Back to Newsroom